Nuwacell is dedicated to developing broadly accessible iPSC-derived cell therapies, advancing a robust pipeline in inflammation repair, tumor immunology, and regenerative medicine. Its therapeutic candidates for KOA, HM, ILD, and other indications are progressing through various stages of clinical development, with continued efforts to explore the full clinical potential of iPSC-based therapies. Shownin, exclusively licensed by Nuwacell, is a leading upstream supplier of key raw materials for cell therapy. The company specializes in hPSC, hMSC, and human immune cell culture systems, as well as iPSC reprogramming and directed differentiation services. Backed by proprietary IP and internationally compliant GMP facilities (B+A/C+A grade), Shownin has supported multiple cell therapy products in securing IND approvals.
Nuwacell Biotech & Shownin Biotech